Alto Neuroscience (ANRO) Stock
Alto Neuroscience (ANRO) closed at $27.12 on Nov 16, 2026; its Tenet Score is 52 of 100 against 313 Healthcare peers.
43 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $27.12
- Nov 16, 2026
- Market cap
- $1.2B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Tenet Score
- 52/100
- Mixed · 313 Healthcare peers
Industry: Pharmaceutical Preparations
Alto Neuroscience Inc. scores 52/100. Mixed. Strongest on financial health, quality is the soft spot versus 313 Healthcare peers. Insufficient inputs: Tenet 52 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=313Factor grades
Growth & Momentum omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Reversal Evidence
- ✕ Quality Floor
- — Munger Compounders
13F flows & insider trades land here.
We are a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Building on more than a decade of research by our founder, Dr. Amit Etkin, we…
Similar-sized companies in Pharmaceutical Preparations
The 5 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| MBX Biosciences Inc.MBX | 52 | $2.7B |
| Septerna Inc.SEPN | 54 | $2.0B |
| Zenas Biopharma Inc.ZBIO | 29 | $1.9B |
| Rapport Therapeutics Inc.RAPP | 59 | $1.6B |
| Bicara Therapeutics Inc.BCAX | 61 | $685.1M |
Common questions
What sector and industry is Alto Neuroscience in?
Alto Neuroscience is in the Healthcare sector and the Pharmaceutical Preparations industry.
What is Alto Neuroscience's Tenet Score?
Alto Neuroscience's Tenet Score is 52 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




